10% CONVERTIBLE PROMISSORY NOTE DUE NOVEMBER 22, 2016Premier Biomedical Inc • March 3rd, 2016 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 3rd, 2016 Industry JurisdictionTHIS 10% CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 10% Convertible Promissory Notes of Premier Biomedical Inc. (the "Company"), having its principal place of business at P.O. Box 31374, El Paso, TX 79930, designated as its 10% Convertible Notes due November 22, 2016 (this Note, the "Note" and, collectively with the other Notes of such series, the "Notes").